• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Nasdaq Jumps 250 Points; Crude Oil Down 1%

    4/11/24 3:21:09 PM ET
    $APVO
    $ELYM
    $ENLV
    $RCEL
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $APVO alert in real time by email

    U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite surging more than 250 points on Thursday.

    The Dow traded up 0.18% to 38,532.50 while the NASDAQ rose 1.63% to 16,433.83. The S&P 500 also rose, gaining, 0.83% to 5,203.26.

    Check This Out: How To Earn $500 A Month From Citigroup Stock Ahead Of Q1 Earnings Report

     

    Leading and Lagging Sectors

     

    Information technology shares rose by 2.2% on Thursday.

    In trading on Thursday, energy shares fell by 0.3%.

     

    Top Headline

     

    Constellation Brands Inc (NYSE:STZ) reported better-than-expected fourth-quarter earnings.

    Constellation Brands reported fourth-quarter FY24 sales growth of 7.1% year-on-year to $2.14 billion, beating the analyst consensus estimate of $2.10 billion. Comparable EPS, excluding Canopy EIE, was $2.30. Comparable EPS of $2.26 beat the consensus estimate of $2.09.

     

    Equities Trading UP

     

    Rallybio Corporation (NASDAQ:RLYB) shares shot up 87% to $3.0419 after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant individuals at risk of FNAIT.

    Shares of Eliem Therapeutics, Inc. (NASDAQ:ELYM) got a boost, surging 58% to $4.2153. The company announced that it entered into a definitive acquisition agreement to acquire Tenet and it also entered into a securities purchase agreement for a $120 million private placement.

    Rent the Runway, Inc. (NASDAQ:RENT) shares were also up, gaining 128% to $16.88 after the company reported mixed fourth-quarter financial results and issued guidance.

     

    Equities Trading DOWN

     

    Aptevo Therapeutics Inc. (NASDAQ:APVO) shares dropped 59% to $0.9870 after the company priced its $4.6 million public offering.

    Shares of Enlivex Therapeutics Ltd. (NASDAQ:ENLV) were down 54% to $1.83. The company announced topline results of its Phase II trial evaluating Allocetra in sepsis.

    AVITA Medical, Inc. (NASDAQ:RCEL) was down, falling 29% to $10.20 after the company announced an update to its expected commercial revenue for the first quarter of 2024. BTIG downgraded the stock from Buy to Neutral.

    Also Check This Out: Top 3 Financial Stocks That Are Ticking Portfolio Bombs

     

    Commodities

     

    In commodity news, oil traded down 1.1% to $85.29 while gold traded up 1.3% at $2,379.80.

    Silver traded up 1.4% to $28.430 on Thursday, while copper fell 0.5% to $4.2605.

     

    Euro zone

     

    European shares were lower today. The eurozone’s STOXX 600 fell 0.40%, London’s FTSE 100 fell 0.47% while Spain’s IBEX 35 Index fell 1.16% The German DAX fell 0.79% French CAC 40 fell 0.27% while Italy’s FTSE MIB Index fell 0.96%.

    The European Central Bank kept interest rates unchanged for a fifth straight time during its April meeting.

     

    Asia Pacific Markets

     

    Asian markets closed mixed on Thursday, with Japan’s Nikkei 225 falling 0.35%, Hong Kong’s Hang Seng Index dropping 0.26%, China’s Shanghai Composite gaining 0.23% and India’s S&P BSE Sensex gaining 0.47%.

    China's consumer prices rose 0.1% year-over-year in March, while producer prices fell by 2.8% year-over-year in March.

     

    Economics

     

    Producer prices in the U.S. rose 0.2% month-over-month in March compared to a 0.6% gain in February. However, analysts were expecting a gain of 0.3%.

    U.S. initial jobless claims declined by 11,000 to 211,000 in the week ending April 6, compared to market estimates of 215,000.

    Now Read This: Citigroup Likely To Report Lower Q1 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

    Get the next $APVO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $APVO
    $ELYM
    $ENLV
    $RCEL

    CompanyDatePrice TargetRatingAnalyst
    Constellation Brands Inc.
    $STZ
    12/17/2025$154.00Buy → Hold
    Jefferies
    Avita Medical Inc.
    $RCEL
    11/20/2025Sell → Neutral
    BTIG Research
    Constellation Brands Inc.
    $STZ
    11/7/2025$153.00Neutral
    Analyst
    Constellation Brands Inc.
    $STZ
    9/12/2025$150.00Overweight → Equal Weight
    Barclays
    Constellation Brands Inc.
    $STZ
    9/3/2025$123.00Neutral → Underperform
    BNP Paribas Exane
    Constellation Brands Inc.
    $STZ
    8/26/2025$150.00Neutral → Underperform
    BofA Securities
    Avita Medical Inc.
    $RCEL
    8/8/2025$3.00Neutral → Sell
    BTIG Research
    Constellation Brands Inc.
    $STZ
    7/7/2025$205.00Hold → Buy
    Jefferies
    More analyst ratings

    $APVO
    $ELYM
    $ENLV
    $RCEL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Constellation Brands downgraded by Jefferies with a new price target

    Jefferies downgraded Constellation Brands from Buy to Hold and set a new price target of $154.00

    12/17/25 8:52:26 AM ET
    $STZ
    Beverages (Production/Distribution)
    Consumer Staples

    Avita Medical upgraded by BTIG Research

    BTIG Research upgraded Avita Medical from Sell to Neutral

    11/20/25 7:57:06 AM ET
    $RCEL
    Medical/Dental Instruments
    Health Care

    Analyst resumed coverage on Constellation Brands with a new price target

    Analyst resumed coverage of Constellation Brands with a rating of Neutral and set a new price target of $153.00

    11/7/25 8:01:21 AM ET
    $STZ
    Beverages (Production/Distribution)
    Consumer Staples

    $APVO
    $ELYM
    $ENLV
    $RCEL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Grant Grady Iii bought $20,134 worth of shares (13,513 units at $1.49), increasing direct ownership by 1,351,300% to 13,514 units (SEC Form 4)

    4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)

    11/12/25 4:33:00 PM ET
    $APVO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Mcnamara Robert bought $45,000 worth of shares (10,000 units at $4.50), increasing direct ownership by 13% to 86,771 units (SEC Form 4)

    4 - AVITA Medical, Inc. (0001762303) (Issuer)

    8/29/25 4:30:09 PM ET
    $RCEL
    Medical/Dental Instruments
    Health Care

    CFO O'Toole David D bought $9,040 worth of shares (2,000 units at $4.52), increasing direct ownership by 7% to 31,657 units (SEC Form 4)

    4 - AVITA Medical, Inc. (0001762303) (Issuer)

    8/26/25 4:30:23 PM ET
    $RCEL
    Medical/Dental Instruments
    Health Care

    $APVO
    $ELYM
    $ENLV
    $RCEL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Rallybio Announces Reverse Stock Split of Common Stock

    Rallybio Corporation (NASDAQ:RLYB) will effect a one-for-eight reverse stock split of its issued and outstanding common stock. Stockholders of Rallybio approved an amendment to Rallybio's Amended and Restated Certificate of Incorporation (the "Amendment") to effect the reverse stock split at a Special Meeting of Stockholders held on January 26, 2026. The reverse stock split is intended to give Rallybio greater flexibility in considering and planning for future potential business needs and to increase the per share trading price of the Rallybio common stock to enable Rallybio to satisfy the minimum price requirement for continued listing on the Nasdaq Capital Market. Pursuant to the Amendmen

    2/3/26 4:05:00 PM ET
    $RLYB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Enlivex Treasury Portfolio Update: Listing of the RAIN Token on WhiteBIT, a Leading Cryptocurrency Exchange

    Listing expected to expand market access and secondary liquidity for Enlivex's primary digital treasury asset Nes-Ziona, Israel, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (NASDAQ:ENLV, "Enlivex" or "the Company")) today reported that its primary treasury asset, the RAIN token, has been listed on the WhiteBIT cryptocurrency exchange effective January 21, 2026, expanding access to the token across a major global digital asset trading platform. WhiteBIT is the largest European cryptocurrency exchange by traffic. Founded in 2018, the platform is part of W Group, which serves more than 35 million customers globally. The commencement of RAIN trading on WhiteBIT is expected t

    1/26/26 8:00:00 AM ET
    $ENLV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies

    First surgeon-reported case using RECELL®, PermeaDerm®, and Cohealyx™ together in a single care pathwayNew clinical and tissue-level data on PermeaDerm and Cohealyx highlight wound bed preparation and readiness for closureRECELL analyses show consistent trends in healing, reduced complications, and shorter hospital stays across studies and real-world registry data VALENCIA, Calif., Jan. 25, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. ((ASX: AVH, NASDAQ:RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today announced data from 19 scientific abstracts, including 14 podium presentations, at the 2026 Boswick Burn & Wound Symposium. The presentations

    1/25/26 5:30:00 PM ET
    $RCEL
    Medical/Dental Instruments
    Health Care

    $APVO
    $ELYM
    $ENLV
    $RCEL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Rosensweig Daniel was granted 16,759 shares, increasing direct ownership by 338% to 21,715 units (SEC Form 4)

    4 - Rent the Runway, Inc. (0001468327) (Issuer)

    12/18/25 4:21:04 PM ET
    $RENT
    Other Specialty Stores
    Consumer Discretionary

    SEC Form 4 filed by Chief Merchant Officer Tam Sarah K

    4 - Rent the Runway, Inc. (0001468327) (Issuer)

    12/18/25 4:19:52 PM ET
    $RENT
    Other Specialty Stores
    Consumer Discretionary

    Director Bariquit Teri was granted 16,759 shares (SEC Form 4)

    4 - Rent the Runway, Inc. (0001468327) (Issuer)

    12/18/25 4:20:28 PM ET
    $RENT
    Other Specialty Stores
    Consumer Discretionary

    $APVO
    $ELYM
    $ENLV
    $RCEL
    SEC Filings

    View All

    SEC Form 6-K filed by Enlivex Therapeutics Ltd.

    6-K - Enlivex Therapeutics Ltd. (0001596812) (Filer)

    2/5/26 7:50:49 AM ET
    $ENLV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Rent the Runway Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Rent the Runway, Inc. (0001468327) (Filer)

    2/3/26 4:43:25 PM ET
    $RENT
    Other Specialty Stores
    Consumer Discretionary

    Aptevo Therapeutics Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - Aptevo Therapeutics Inc. (0001671584) (Filer)

    2/3/26 8:15:25 AM ET
    $APVO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $APVO
    $ELYM
    $ENLV
    $RCEL
    Leadership Updates

    Live Leadership Updates

    View All

    AVITA Medical Announces Changes to its Board of Directors

    Veteran healthcare executive Joe Woody joins the BoardLou Panaccio retires after over a decade of service VALENCIA, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. ((ASX: AVH, NASDAQ:RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today announced the appointment of Joe Woody as a new non-executive Director and the retirement of Lou Panaccio, who served as Chairman from July 2014 to August 2025. "We are pleased to welcome Joe to the Board. His extensive track record leading global med-tech companies and driving commercial excellence will be invaluable as we continue to scale AVITA Medical's growth," said Cary Vance, Interim CEO of

    1/5/26 4:05:00 PM ET
    $RCEL
    Medical/Dental Instruments
    Health Care

    Enlivex Appoints former Italy Prime Minister Matteo Renzi to Board of Directors

    Enlivex Announced today $212,000,000 private placement to initiate world's first prediction markets digital asset treasury strategy, via RAIN token accumulation NESS ZIONA, Israel, Nov. 24, 2025 /PRNewswire/ -- Enlivex Therapeutics Ltd. (NASDAQ:ENLV) today announced the appointment of Mr. Matteo Renzi, former Prime Minister of Italy, to the board of directors at Enlivex, effective November 24th. 2025. Enlivex Therapeutics Ltd., a clinical-stage macrophage reprogramming immunotherapy company, today announced that it has entered into a securities purchase agreement for a private investment in public equity (PIPE) for the purchase and sale of 212,000,000 ordinary shares (or ordinary share equi

    11/24/25 10:00:00 AM ET
    $ENLV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Enlivex Announces $212,000,000 Private Placement to Initiate World's First Prediction Markets Digital Asset Treasury Strategy, via RAIN token Accumulation, and the Appointment of Matteo Renzi, Former Prime Minister of Italy, to its Board

    - Upon the closing of the private placement, Enlivex will adopt the world's first RAIN prediction markets token digital asset treasury strategy, via RAIN token accumulation. - RAIN is a fully decentralized predictions and options protocol that redefines predictive market ecosystems and provides a powerful platform for on-chain market creation - built for transparency, automation, and community participation. - Mr. Matteo Renzi, former Prime Minister of Italy, will be appointed to the Enlivex Board of Directors following closing of the private placement. - Enlivex to continue clinical development of Allocetra™, a potentially game-changing knee osteoarthritis therapeutic, a growing market w

    11/24/25 7:55:00 AM ET
    $ENLV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $APVO
    $ELYM
    $ENLV
    $RCEL
    Financials

    Live finance-specific insights

    View All

    AVITA Medical: Pre-J.P. Morgan Update Highlights 2025 Revenue Growth, New Debt Facility, and 2026 Growth Outlook

    VALENCIA, Calif., Jan. 13, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. ((ASX: AVH, NASDAQ:RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today announced unaudited preliminary financial results and a business update for the fourth quarter and fiscal year 2025. The Company also provided its preliminary outlook for fiscal year 2026, ahead of its presentation at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 at 5:15 p.m. Pacific Time (Thursday, January 15, 2026, at 12:15 p.m. Australian Eastern Daylight Time). The webcast can be accessed through AVITA Medical's website at: https://ir.avitamedical.com/events-and-presentations

    1/13/26 8:25:00 AM ET
    $RCEL
    Medical/Dental Instruments
    Health Care

    Constellation Brands Reports Third Quarter Fiscal 2026 Financial Results

    ROCHESTER, N.Y., Jan. 07, 2026 (GLOBE NEWSWIRE) --  Constellation Brands, Inc. (NYSE:STZ), a leading beverage alcohol company, reported today its third quarter fiscal 2026 financial results. A conference call to discuss the financial results and outlook will be hosted by President and Chief Executive Officer, Bill Newlands, and Chief Financial Officer, Garth Hankinson, on Thursday, January 8, 2026 at 10:30 a.m. ET. Visit ir.cbrands.com to locate information for joining the conference call, or a live, listen-only webcast of the conference call. ABOUT CONSTELLATION BRANDSConstellation Brands (NYSE:STZ) is a leading international producer and marketer of beer, wine, and spirits with operatio

    1/7/26 4:05:00 PM ET
    $STZ
    Beverages (Production/Distribution)
    Consumer Staples

    Rent the Runway, Inc. Announces Third Quarter 2025 Results

    Continued Growth of the Business with Q3 Ending Active Subscribers +12.4% YoY; Revenue up 15.4% YOY Closed Transformative Recapitalization Plan, Strengthening the Balance Sheet and Injecting Capital into the Business Expanded our Community-driven Organic Growth Strategy to Drive Brand Awareness and Acquisition NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Rent the Runway, Inc. ("Rent the Runway" or "RTR") (NASDAQ:RENT), the company transforming the way women get dressed, today reported financial results for the fiscal quarter ended October 31, 2025. Rent the Runway is delivering on its multi-year transformation plan, achieving substantial growth on the heels of its largest inventory inve

    12/12/25 8:01:00 AM ET
    $RENT
    Other Specialty Stores
    Consumer Discretionary

    $APVO
    $ELYM
    $ENLV
    $RCEL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Rent the Runway Inc.

    SC 13G/A - Rent the Runway, Inc. (0001468327) (Subject)

    11/14/24 5:08:56 PM ET
    $RENT
    Other Specialty Stores
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Aptevo Therapeutics Inc.

    SC 13G/A - Aptevo Therapeutics Inc. (0001671584) (Subject)

    11/14/24 3:45:38 PM ET
    $APVO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Enlivex Therapeutics Ltd.

    SC 13G - Enlivex Therapeutics Ltd. (0001596812) (Subject)

    11/14/24 3:29:35 PM ET
    $ENLV
    Biotechnology: Pharmaceutical Preparations
    Health Care